{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:56:06Z","timestamp":1788454566325,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":53,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319717784","type":"print"},{"value":"9783319717791","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-71779-1_16","type":"book-chapter","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T04:51:01Z","timestamp":1518151861000},"page":"309-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)\/Machado-Joseph Disease (MJD)"],"prefix":"10.1007","author":[{"given":"Manuela","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"issue":"3","key":"16_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42(3):174\u2013183","journal-title":"Neuroepidemiology"},{"key":"16_CR2","volume-title":"Non-mendelian genetic aspects in spinocerebellar ataxias (scas): the case of Machado-Joseph disease (MJD)","author":"M Lima","year":"2012","unstructured":"Lima M, Bruges-Armas J, Bettencourt C (2012) Non-mendelian genetic aspects in spinocerebellar ataxias (scas): the case of Machado-Joseph disease (MJD). Spinocerebellar Ataxia, InTech"},{"key":"16_CR3","unstructured":"Coutinho P (1992) Doen\u00e7a de Machado-Joseph: Tentativa de defini\u00e7\u00e3o. PhD dissertation, Universidade do Porto"},{"issue":"3","key":"16_CR4","first-page":"383","volume":"69","author":"M Lima","year":"1997","unstructured":"Lima M, Mayer F, Coutinho P, Abade A (1997) Prevalence, geographic distribution, and genealogical investigation of Machado-Joseph disease in the Azores (Portugal). Hum Biol 69(3):383\u2013391","journal-title":"Hum Biol"},{"issue":"6","key":"16_CR5","first-page":"1011","volume":"70","author":"M Lima","year":"1998","unstructured":"Lima M, Mayer FM, Coutinho P, Abade A (1998) Origins of a mutation: population genetics of Machado-Joseph disease in the Azores (Portugal). Hum Biol Int Rec Res 70(6):1011\u20131023","journal-title":"Hum Biol Int Rec Res"},{"issue":"7","key":"16_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/mds.26238","volume":"30","author":"M Raposo","year":"2015","unstructured":"Raposo M, Bettencourt C, Maciel P, Gao F, Ramos A et al (2015) Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease. Mov Disord 30(7):968\u2013975","journal-title":"Mov Disord"},{"issue":"1","key":"16_CR7","first-page":"1001","volume":"1","author":"M Ara\u00fajo de","year":"2016","unstructured":"de Ara\u00fajo M, Raposo M, Kazachkova N, Vasconcelos J, Kay T, Lima M (2016) Trends in the epidemiology of spinocerebellar ataxia type 3\/Machado-Joseph disease in the Azores Islands, Portugal. JSM Brain Sci 1(1):1001","journal-title":"JSM Brain Sci"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-6-35","volume":"6","author":"C Bettencourt","year":"2011","unstructured":"Bettencourt C, Lima M (2011) Machado-Joseph disease: from first descriptions to new perspectives. Orphanet J Rare Dis 6:35","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"16_CR9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/archneurol.2011.636","volume":"68","author":"C Bettencourt","year":"2011","unstructured":"Bettencourt C, Raposo M, Kazachkova N, Cymbron T, Santos C et al (2011) The APOE \u03b52 allele increases the risk of earlier age at onset in Machado-Joseph disease. Arch Neurol 68(12):1580\u20131583","journal-title":"Arch Neurol"},{"key":"16_CR10","first-page":"139","volume":"61","author":"J Sequeiros","year":"1993","unstructured":"Sequeiros J, Coutinho P (1993) Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol 61:139\u2013153","journal-title":"Adv Neurol"},{"issue":"10","key":"16_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10038-008-0330-y","volume":"53","author":"C Bettencourt","year":"2008","unstructured":"Bettencourt C, Santos C, Kay T, Vasconcelos J, Lima M (2008) Analysis of segregation patterns in Machado-Joseph disease pedigrees. J Hum Genet 53(10):920\u2013923","journal-title":"J Hum Genet"},{"issue":"3","key":"16_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng1194-221","volume":"8","author":"Y Kawaguchi","year":"1994","unstructured":"Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M et al (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8(3):221\u2013228","journal-title":"Nat Genet"},{"issue":"11","key":"16_CR13","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","volume":"58","author":"P Maciel","year":"2001","unstructured":"Maciel P, Costa MC, Ferro A, Rousseau M, Santos CS et al (2001) Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol 58(11):1821\u20131827","journal-title":"Arch Neurol"},{"issue":"2","key":"16_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cge.12719","volume":"90","author":"GN Souza","year":"2016","unstructured":"Souza GN, Kersting N, Krum-Santos AC, Santos ASP, Furtado GV et al (2016) Spinocerebellar ataxia type 3\/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions. Clin Genet 90(2):134\u2013140","journal-title":"Clin Genet"},{"issue":"3","key":"16_CR15","first-page":"1513","volume":"49","author":"MM Evers","year":"2014","unstructured":"Evers MM, Toonen LJA, van Roon-Mom WMC (2014) Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies. Mol Neurobiol 49(3):1513\u20131531","journal-title":"Mol Neurobiol"},{"issue":"2","key":"16_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pneurobio.2011.11.006","volume":"97","author":"MC Costa do","year":"2012","unstructured":"do Costa MC, Paulson HL (2012) Toward understanding Machado-Joseph disease. Prog Neurobiol 97(2):239\u2013257","journal-title":"Prog Neurobiol"},{"key":"16_CR17","doi-asserted-by":"crossref","unstructured":"Kazachkova N, Lima M (2015) Towards a therapeutic intervention in polyglutamine ataxias: from models to clinical trials. In: Atta-ur-Rahman (ed) Frontiers in clinical drug research -CNS and neurological disorders, pp. 77\u2013130","DOI":"10.2174\/9781608059263114030006"},{"issue":"1\u20132","key":"16_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jns.2015.08.019","volume":"358","author":"JAM Saute","year":"2015","unstructured":"Saute JAM, Rieder CRM, Castilhos RM, Monte TL, Schumacher-Schuh AF et al (2015) Planning future clinical trials in Machado Joseph disease: lessons from a phase 2 trial. J Neurol Sci 358(1\u20132):72\u201376","journal-title":"J Neurol Sci"},{"issue":"3","key":"16_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89\u201395","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"16_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","volume":"10","author":"DW Weir","year":"2011","unstructured":"Weir DW, Sturrock A, Leavitt BR (2011) Development of biomarkers for Huntington\u2019s disease. Lancet Neurol 10(6):573\u2013590","journal-title":"Lancet Neurol"},{"issue":"Pt 12","key":"16_CR21","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1093\/brain\/awv206","volume":"138","author":"M Raposo","year":"2015","unstructured":"Raposo M, Ramos A, Bettencourt C, Lima M (2015) Replicating studies of genetic modifiers in spinocerebellar ataxia type 3: can homogeneous cohorts aid? Brain 138(Pt 12):e398","journal-title":"Brain"},{"issue":"3","key":"16_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1034\/j.1600-0404.2003.00046.x","volume":"107","author":"L Jardim","year":"2003","unstructured":"Jardim L, Silveira I, do Pereira ML, C\u00e9u Moreira M, Mendon\u00e7a P et al (2003) Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype. Acta Neurol Scand 107(3):211\u2013214","journal-title":"Acta Neurol Scand"},{"issue":"Pt 9","key":"16_CR23","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/brain\/awu174","volume":"137","author":"S Tezenas du Montcel","year":"2014","unstructured":"Tezenas du Montcel S, Durr A, Bauer P, Figueroa K, Ichikawa Y et al (2014) Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 137(Pt 9):2444\u20132455","journal-title":"Brain"},{"issue":"1","key":"16_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12017-016-8416-8","volume":"19","author":"Mafalda Raposo","year":"2016","unstructured":"Raposo M, Bettencourt C, Ramos A, Kazachkova N, Vasconcelos J et al (2016) Promoter variation and expression levels of inflammatory genes IL1A, IL1B, IL6 and TNF in blood of spinocerebellar ataxia type 3 (SCA3) patients. Neuromolecular Med 19(1):41\u201345","journal-title":"NeuroMolecular Medicine"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2377-11-131","volume":"11","author":"C Bettencourt","year":"2011","unstructured":"Bettencourt C, Santos C, Coutinho P, Rizzu P, Vasconcelos J et al (2011) Parkinsonian phenotype in Machado-Joseph disease (MJD\/SCA3): a two-case report. BMC Neurol 11:131","journal-title":"BMC Neurol"},{"issue":"9","key":"16_CR26","doi-asserted-by":"publisher","first-page":"2179.e15-2179.e","DOI":"10.1016\/j.neurobiolaging.2014.03.020","volume":"35","author":"Huirong Peng","year":"2014","unstructured":"Peng H, Wang C, Chen Z, Sun Z, Jiao B et al (2014) APOE \u03b52 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population. Neurobiol Aging 35(9):2179.e15\u20132179.e18","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"16_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.parkreldis.2011.09.024","volume":"18","author":"M Siebert","year":"2012","unstructured":"Siebert M, Donis KC, Socal M, Rieder C, Emmel VE et al (2012) Glucocerebrosidase gene variants in parkinsonian patients with Machado Joseph\/spinocerebellar ataxia 3. Park Relat Disord 18(2):185\u2013190","journal-title":"Park Relat Disord"},{"issue":"2","key":"16_CR28","doi-asserted-by":"publisher","first-page":"e0117488","DOI":"10.1371\/journal.pone.0117488","volume":"10","author":"Z Long","year":"2015","unstructured":"Long Z, Chen Z, Wang C, Huang F, Peng H et al (2015) Two novel SNPs in ATXN3 3\u2019 UTR may decrease age at onset of SCA3\/MJD in Chinese patients. PLoS One 10(2):e0117488","journal-title":"PLoS One"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fneur.2012.00164","volume":"3","author":"MC Fran\u00e7a","year":"2012","unstructured":"Fran\u00e7a MC, Emmel VE, D\u2019Abreu A, Maurer-Morelli CV, Secolin R et al (2012) Normal ATXN3 allele but not CHIP polymorphisms modulates age at onset in Machado-Joseph disease. Front Neurol 3:164","journal-title":"Front Neurol"},{"issue":"8","key":"16_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/gm80","volume":"1","author":"JF Gusella","year":"2009","unstructured":"Gusella JF, MacDonald ME (2009) Huntington\u2019s disease: the case for genetic modifiers. Genome Med 1(8):80","journal-title":"Genome Med"},{"issue":"48","key":"16_CR31","doi-asserted-by":"publisher","first-page":"44889","DOI":"10.1074\/jbc.M106575200","volume":"276","author":"Y Chai","year":"2001","unstructured":"Chai Y, Wu L, Griffin JD, Paulson HL (2001) The role of protein composition in specifying nuclear inclusion formation in polyglutamine disease. J Biol Chem 276(48):44889\u201344897","journal-title":"J Biol Chem"},{"issue":"6","key":"16_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1083\/jcb.143.6.1457","volume":"143","author":"MK Perez","year":"1998","unstructured":"Perez MK, Paulson HL, Pendse SJ, Saionz SJ, Bonini NM, Pittman RN (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol 143(6):1457\u20131470","journal-title":"J Cell Biol"},{"issue":"4","key":"16_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/jnen\/60.4.369","volume":"60","author":"J Takahashi","year":"2001","unstructured":"Takahashi J, Tanaka J, Arai K, Funata N, Hattori T et al (2001) Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol 60(4):369\u2013376","journal-title":"J Neuropathol Exp Neurol"},{"issue":"44","key":"16_CR34","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1523\/JNEUROSCI.2053-06.2006","volume":"26","author":"BO Evert","year":"2006","unstructured":"Evert BO, Araujo J, Vieira-Saecker AM, de Vos RAI, Harendza S et al (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J Neurosci 26(44):11474\u201311486","journal-title":"J Neurosci"},{"issue":"10","key":"16_CR35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/jnen\/62.10.1006","volume":"62","author":"BO Evert","year":"2003","unstructured":"Evert BO, Vogt IR, Vieira-Saecker AM, Ozimek L, de Vos RAI et al (2003) Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J Neuropathol Exp Neurol 62(10):1006\u20131018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"47","key":"16_CR36","doi-asserted-by":"publisher","first-page":"45004","DOI":"10.1074\/jbc.M205259200","volume":"277","author":"F Li","year":"2002","unstructured":"Li F, Macfarlan T, Pittman RN, Chakravarti D (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem 277(47):45004\u201345012","journal-title":"J Biol Chem"},{"issue":"30","key":"16_CR37","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1073\/pnas.0501732102","volume":"102","author":"G Nicastro","year":"2005","unstructured":"Nicastro G, Menon RP, Masino L, Knowles PP, McDonald NQ, Pastore A (2005) The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc Natl Acad Sci USA 102(30):10493\u201310498","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"16_CR38","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1096\/fj.06-7002com","volume":"21","author":"A-J Rodrigues","year":"2007","unstructured":"Rodrigues A-J, Coppola G, Santos C, do Costa MC, Ailion M et al (2007) Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. FASEB J. 21(4):1126\u20131136","journal-title":"FASEB J."},{"issue":"1","key":"16_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","volume":"31","author":"A-H Chou","year":"2008","unstructured":"Chou A-H, Yeh T-H, Ouyang P, Chen Y-L, Chen S-Y, Wang H-L (2008) Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol Dis 31(1):89\u2013101","journal-title":"Neurobiol Dis"},{"issue":"15","key":"16_CR40","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","volume":"21","author":"BO Evert","year":"2001","unstructured":"Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA et al (2001) Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci 21(15):5389\u20135396","journal-title":"J Neurosci"},{"key":"16_CR41","unstructured":"Raposo M (2017) Predicting and tracking Machado-Joseph disease: biomarkers of diagnosis and prognosis. PhD dissertation, Universidade dos A\u00e7ores"},{"issue":"1\u20132","key":"16_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-510X(96)00159-1","volume":"142","author":"T Matsuishi","year":"1996","unstructured":"Matsuishi T, Sakai T, Nagamitsu S, Shoji H, Ueda N et al (1996) Decreased cerebrospinal fluid levels of substance P in Machado-Joseph disease. J Neurol Sci 142(1\u20132):107\u2013110","journal-title":"J Neurol Sci"},{"issue":"2","key":"16_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mrgentox.2013.06.023","volume":"757","author":"LS Pacheco","year":"2013","unstructured":"Pacheco LS, da Silveira AF, Trott A, Houenou LJ, Algarve TD et al (2013) Association between Machado-Joseph disease and oxidative stress biomarkers. Mutat Res 757(2):99\u2013103","journal-title":"Mutat Res"},{"issue":"8","key":"16_CR44","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/jnr.22011","volume":"87","author":"Y-C Yu","year":"2009","unstructured":"Yu Y-C, Kuo C-L, Cheng W-L, Liu C-S, Hsieh M (2009) Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J Neurosci Res 87(8):1884\u20131891","journal-title":"J Neurosci Res"},{"issue":"4","key":"16_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000339207","volume":"11","author":"N Kazachkova","year":"2013","unstructured":"Kazachkova N, Raposo M, Montiel R, Cymbron T, Bettencourt C et al (2013) Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease. Neurodegener Dis 11(4):206\u2013214","journal-title":"Neurodegener Dis"},{"issue":"1\u20132","key":"16_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2007.07.016","volume":"264","author":"C-S Liu","year":"2008","unstructured":"Liu C-S, Cheng W-L, Kuo S-J, Li J-Y, Soong B-W, Wei Y-H (2008) Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases. J Neurol Sci 264(1\u20132):18\u201321","journal-title":"J Neurol Sci"},{"issue":"2","key":"16_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s12031-014-0360-1","volume":"55","author":"A Ramos","year":"2015","unstructured":"Ramos A, Kazachkova N, Silva F, Maciel P, Silva-Fernandes A et al (2015) Differential mtDNA damage patterns in a transgenic mouse model of Machado-Joseph disease (MJD\/SCA3). J Mol Neurosci 55(2):449\u2013453","journal-title":"J Mol Neurosci"},{"issue":"1","key":"16_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jocn.2011.05.011","volume":"19","author":"A Zeng","year":"2012","unstructured":"Zeng A, Liu X, Shen L, Li W, Ding Z et al (2012) Analysis of mitochondrial DNA variations in a Chinese family with spinocerebellar ataxia. J Clin Neurosci 19(1):60\u201364","journal-title":"J Clin Neurosci"},{"key":"16_CR49","unstructured":"Raposo M, Ramos A, Kazachkova N, Teixeira B, Bettencourt C, Lima M (submitted)\nAccumulation of mitochondrial DNA common deletion since the preataxic stage of Machado-Joseph disease"},{"key":"16_CR50","doi-asserted-by":"crossref","unstructured":"Kazachkova N, Raposo M, Ramos A, Montiel R, Lima M (2017) Promoter variant alters expression of the Autophagic BECN1 gene: implications for clinical manifestations of Machado-Joseph disease. The Cerebellum","DOI":"10.1007\/s12311-017-0875-4"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1038\/ncomms11445","volume":"7","author":"Janete Cunha-Santos","year":"2016","unstructured":"Cunha-Santos J, Duarte-Neves J, Carmona V, Guarente L, Pereira de Almeida L, Cavadas C (2016) Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway. Nat Commun 11(7):11445","journal-title":"Nature Communications"},{"key":"16_CR52","doi-asserted-by":"crossref","unstructured":"da Silva Carvalho G, Saute JAM, Haas CB, Torrez VR, Brochier AW, Souza GN, Furtado GV, Gheno T, Russo A, Monte TL, Schumacher-Schuh A, D\u2019Avila R, Donis KC, Castilhos RM, Souza DO, Saraiva-Pereira ML, Torman VL, Camey S, Portela LV, Jardim LB (2016) Cytokines in Machado Joseph disease\/Spinocerebellar Ataxia 3. The Cerebellum 15(4):518\u2013525","DOI":"10.1007\/s12311-015-0719-z"},{"issue":"4","key":"16_CR53","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/mds.23428","volume":"26","author":"Jonas Alex Morales Saute","year":"2010","unstructured":"Saute JAM, da Silva ACF, Muller AP, Hansel G, de Mello AS, Maeda F, Vedolin L, Saraiva-Pereira ML, Souza DO, Arpa J, Torres-Aleman I, Portela LVC, Jardim LB (2011) Serum insulin-like system alterations in patients with Spinocerebellar Ataxia type 3. Mov Disord 26(4):731\u2013735","journal-title":"Movement Disorders"}],"container-title":["Advances in Experimental Medicine and Biology","Polyglutamine Disorders"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-71779-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T23:33:51Z","timestamp":1523316831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-71779-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319717784","9783319717791"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-71779-1_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}